GIPM
MED icon

G2 Investment Partners Management’s Medifast MED Stock Holding History

G2 Investment Partners Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-56,404
Closed -$5.84M – 90
2019
Q3 		$5.84M Sell
56,404
-15,761
-22% -$1.69M 1.66% 28
2019
Q2 		$9.26M Buy
72,165
+50,528
+234% +$7.02M 2.91% 12
2019
Q1 		$2.76M Buy
21,637
+19,137
+765% +$2.43M 0.85% 36
2018
Q4 		$313K Buy
+2,500
New +$428K 0.13% 59

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

G2 Investment Partners Management's MED Position: Q4 2019 in Review

G2 Investment Partners Management sold out of Medifast (MED) in Q4 2019, closing a stake of 56,404 shares — an estimated $5.84M sold.

G2 Investment Partners Management first reported a position in MED in Q4 2018 and held it in 4 quarters. The position peaked at $9.26M in Q2 2019. 219 funds tracked by Wall St. Rank hold MED as of Q4 2019.

  • G2 Investment Partners Management reported no remaining Medifast position as of Q4 2019 after selling out during the quarter.
  • G2 Investment Partners Management sold 56,404 Medifast shares in Q4 2019, an estimated $5.84M.
  • G2 Investment Partners Management first reported a position in Medifast in Q4 2018 and held it in 4 quarters.
  • G2 Investment Partners Management's Medifast position peaked at $9.26M in Q2 2019.
  • 219 funds tracked by Wall St. Rank held Medifast as of Q4 2019.

Based on G2 Investment Partners Management's 13F filing for Q4 2019, filed 14 Feb 2020.